Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials

Abstract Background Infarct evolution rate and response to acute reperfusion therapy may differ between patients, which is important to consider for accurate management and treatment of patients with ST-elevation myocardial infarction (STEMI). The aim of this study was therefore to investigate the a...

Full description

Bibliographic Details
Main Authors: David Nordlund, Henrik Engblom, Jean-Louis Bonnet, Henrik Steen Hansen, Dan Atar, David Erlinge, Ulf Ekelund, Einar Heiberg, Marcus Carlsson, Håkan Arheden
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Sex
Online Access:http://link.springer.com/article/10.1186/s12872-019-1139-7
id doaj-a0b77ed4f7864b2c8ba605cb462026c8
record_format Article
spelling doaj-a0b77ed4f7864b2c8ba605cb462026c82020-11-25T03:38:45ZengBMCBMC Cardiovascular Disorders1471-22612019-07-0119111010.1186/s12872-019-1139-7Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trialsDavid Nordlund0Henrik Engblom1Jean-Louis Bonnet2Henrik Steen Hansen3Dan Atar4David Erlinge5Ulf Ekelund6Einar Heiberg7Marcus Carlsson8Håkan Arheden9Department of Clinical Physiology, Clinical Sciences, Lund UniversityDepartment of Clinical Physiology, Clinical Sciences, Lund UniversityAssistance Publique Hôpitaux de Marseille, Hôpital La TimoneDepartment of Cardiology B, Odense University HospitalDepartment of Cardiology B, Oslo University Hospital Ullevål, and Faculty of Medicine, University of OsloDepartment of Cardiology, Clinical Sciences, Lund UniversityDepartment of Emergency Medicine, Clinical Sciences, Lund UniversityDepartment of Clinical Physiology, Clinical Sciences, Lund UniversityDepartment of Clinical Physiology, Clinical Sciences, Lund UniversityDepartment of Clinical Physiology, Clinical Sciences, Lund UniversityAbstract Background Infarct evolution rate and response to acute reperfusion therapy may differ between patients, which is important to consider for accurate management and treatment of patients with ST-elevation myocardial infarction (STEMI). The aim of this study was therefore to investigate the association of infarct size and myocardial salvage with gender, smoking status, presence of diabetes or history of hypertension in a cohort of STEMI-patients. Methods Patients (n = 301) with first-time STEMI from the three recent multi-center trials (CHILL-MI, MITOCARE and SOCCER) underwent cardiac magnetic resonance (CMR) imaging to determine myocardium at risk (MaR) and infarct size (IS). Myocardial salvage index (MSI) was calculated as MSI = 1-IS/MaR. Pain to balloon time, culprit vessel, trial treatments, age, TIMI grade flow and collateral flow by Rentrop grading were included as explanatory variables in the statistical model. Results Women (n = 66) had significantly smaller MaR (mean difference: 5.0 ± 1.5% of left ventricle (LV), p < 0.01), smaller IS (mean difference: 5.1 ± 1.4% of LV, p = 0.03), and larger MSI (mean difference: 9.6 ± 2.8% of LV, p < 0.01) compared to men (n = 238). These differences remained significant when adjusting for other explanatory variables. There were no significant effects on MaR, IS or MSI for diabetes, hypertension or smoking. Conclusions Female gender is associated with higher myocardial salvage and smaller infarct size suggesting a pathophysiological difference in infarct evolution between men and women.http://link.springer.com/article/10.1186/s12872-019-1139-7Area at riskGenderSexDiabetesHypertension
collection DOAJ
language English
format Article
sources DOAJ
author David Nordlund
Henrik Engblom
Jean-Louis Bonnet
Henrik Steen Hansen
Dan Atar
David Erlinge
Ulf Ekelund
Einar Heiberg
Marcus Carlsson
Håkan Arheden
spellingShingle David Nordlund
Henrik Engblom
Jean-Louis Bonnet
Henrik Steen Hansen
Dan Atar
David Erlinge
Ulf Ekelund
Einar Heiberg
Marcus Carlsson
Håkan Arheden
Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials
BMC Cardiovascular Disorders
Area at risk
Gender
Sex
Diabetes
Hypertension
author_facet David Nordlund
Henrik Engblom
Jean-Louis Bonnet
Henrik Steen Hansen
Dan Atar
David Erlinge
Ulf Ekelund
Einar Heiberg
Marcus Carlsson
Håkan Arheden
author_sort David Nordlund
title Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials
title_short Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials
title_full Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials
title_fullStr Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials
title_full_unstemmed Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials
title_sort gender but not diabetes, hypertension or smoking affects infarct evolution in st-elevation myocardial infarction patients – data from the chill-mi, mitocare and soccer trials
publisher BMC
series BMC Cardiovascular Disorders
issn 1471-2261
publishDate 2019-07-01
description Abstract Background Infarct evolution rate and response to acute reperfusion therapy may differ between patients, which is important to consider for accurate management and treatment of patients with ST-elevation myocardial infarction (STEMI). The aim of this study was therefore to investigate the association of infarct size and myocardial salvage with gender, smoking status, presence of diabetes or history of hypertension in a cohort of STEMI-patients. Methods Patients (n = 301) with first-time STEMI from the three recent multi-center trials (CHILL-MI, MITOCARE and SOCCER) underwent cardiac magnetic resonance (CMR) imaging to determine myocardium at risk (MaR) and infarct size (IS). Myocardial salvage index (MSI) was calculated as MSI = 1-IS/MaR. Pain to balloon time, culprit vessel, trial treatments, age, TIMI grade flow and collateral flow by Rentrop grading were included as explanatory variables in the statistical model. Results Women (n = 66) had significantly smaller MaR (mean difference: 5.0 ± 1.5% of left ventricle (LV), p < 0.01), smaller IS (mean difference: 5.1 ± 1.4% of LV, p = 0.03), and larger MSI (mean difference: 9.6 ± 2.8% of LV, p < 0.01) compared to men (n = 238). These differences remained significant when adjusting for other explanatory variables. There were no significant effects on MaR, IS or MSI for diabetes, hypertension or smoking. Conclusions Female gender is associated with higher myocardial salvage and smaller infarct size suggesting a pathophysiological difference in infarct evolution between men and women.
topic Area at risk
Gender
Sex
Diabetes
Hypertension
url http://link.springer.com/article/10.1186/s12872-019-1139-7
work_keys_str_mv AT davidnordlund genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT henrikengblom genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT jeanlouisbonnet genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT henriksteenhansen genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT danatar genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT daviderlinge genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT ulfekelund genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT einarheiberg genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT marcuscarlsson genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
AT hakanarheden genderbutnotdiabeteshypertensionorsmokingaffectsinfarctevolutioninstelevationmyocardialinfarctionpatientsdatafromthechillmimitocareandsoccertrials
_version_ 1724540755409633280